Deci E, Ryan R Handbook of Self-determination. Research. Rochester, NY: University of Rochester Press; 2002.
Falk DE, Yi HY, Hiller-Sturmhofel S An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Alcohol Res Health. 2006;29(3):162-71.
Hart CL, Davey Smith G, Gruer L, Watt GC The combined effect of smoking tobacco and drinking alcohol on cause-specific mortality: a 30 year cohort study. BMC Public Health. 2010 Dec 24;10:789. doi: 10.1186/1471-2458-10-789.
Joseph AM, Nelson DB, Nugent SM, Willenbring ML Timing of alcohol and smoking cessation (TASC): smoking among substance use patients screened and enrolled in a clinical trial. J Addict Dis. 2003;22(4):87-107. doi: 10.1300/j069v22n04_08.
Lam TH, Chan B, Ho SY, Chan WM Stage of change for general health promotion action and health-related lifestyle practices in Chinese adults. Prev Med. 2004 Mar;38(3):302-8. doi: 10.1016/j.ypmed.2003.10.005.
Leeman RF, McKee SA, Toll BA, Krishnan-Sarin S, Cooney JL, Makuch RW, O'Malley SS Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder. Nicotine Tob Res. 2008 Dec;10(12):1793-809. doi: 10.1080/14622200802443742. Erratum In: Nicotine Tob Res. 2009 Sep;11(9):1126.
Milosevic I, Levy HC, Alcolado GM, Radomsky AS The Treatment Acceptability/Adherence Scale: Moving Beyond the Assessment of Treatment Effectiveness. Cogn Behav Ther. 2015;44(6):456-69. doi: 10.1080/16506073.2015.1053407. Epub 2015 Jun 19.
Przulj D, Hajek P, Snuggs S, McRobbie H Changes in Alcohol Consumption During a Stop-Smoking Attempt and Differences Between Smokers Using Nicotine Replacement and Smokers Using Varenicline. Nicotine Tob Res. 2018 Apr 2;20(5):583-588. doi: 10.1093/ntr/ntx105.
The Lancet Tobacco elimination: an economic and public health imperative. Lancet. 2017 Jan 21;389(10066):225. doi: 10.1016/S0140-6736(17)30132-0. Epub 2017 Jan 20. No abstract available.
Thorne S Interpretive description. Developing qualitative inquiry. 2008.
World Health Organization AUDIT: The alcohol use disorders identification test: Guidelines for use in primary health care. World Health Organization; 2001.
Yardley MM, Mirbaba MM, Ray LA Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers. CNS Drugs. 2015;29(10):833-45. doi: 10.1007/s40263-015-0284-5.
Development and a Pilot Randomized Controlled Trial of a Brief Alcohol Intervention During Smoking Cessation Treatment Delivered by Healthcare Professionals
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
